Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Henry W Long

Showing results (81-90 of 91) with videos related to

Pageof 10
Sort By:
Cancer Cell|February 19, 2019
ARv7 Represses Tumor-Suppressor Genes in Castration-Resistant Prostate CancerLaura Cato, Jonas de Tribolet-Hardy, Irene Lee, et al.
Molecular Cancer Therapeutics|February 27, 2024
Thio-2 Inhibits Key Signaling Pathways Required for the Development and Progression of Castration-resistant Prostate CancerAntje Neeb, Ines Figueiredo, Denisa Bogdan, et al.
Nature Genetics|June 2, 2025
KDM4C inhibition blocks tumor growth in basal breast cancer by promoting cathepsin L-mediated histone H3 cleavageZheqi Li, Guillermo Peluffo, Laura E Stevens, et al.
Nature Communications|March 31, 2021
Reprogramming of the FOXA1 cistrome in treatment-emergent neuroendocrine prostate cancerSylvan C Baca, David Y Takeda, Ji-Heui Seo, et al.
Nature Cancer|April 26, 2021
EZH2 inhibition activates a dsRNA-STING-interferon stress axis that potentiates response to PD-1 checkpoint blockade in prostate cancerKatherine L Morel, Anjali V Sheahan, Deborah L Burkhart, et al.
Cancer Cell|January 15, 2020
Treatment-Induced Tumor Dormancy through YAP-Mediated Transcriptional Reprogramming of the Apoptotic PathwayKari J Kurppa, Yao Liu, Ciric To, et al.
Nature Genetics|July 22, 2020
Prostate cancer reactivates developmental epigenomic programs during metastatic progressionMark M Pomerantz, Xintao Qiu, Yanyun Zhu, et al.
Nature Communications|September 15, 2019
Perturbed myoepithelial cell differentiation in BRCA mutation carriers and in ductal carcinoma in situLina Ding, Ying Su, Anne Fassl, et al.
The Journal of Clinical Investigation|June 10, 2025
Patterns of intra- and inter-tumor phenotypic heterogeneity in lethal prostate cancerMartine P Roudier, Roman Gulati, Erolcan Sayar, et al.
Cell|March 1, 2025
HIF regulates multiple translated endogenous retroviruses: Implications for cancer immunotherapyQinqin Jiang, David A Braun, Karl R Clauser, et al.
Pageof 10

Showing results (81-90 of 91) with videos related to

Sort By:
Pageof 10
Cancer Cell|February 19, 2019
ARv7 Represses Tumor-Suppressor Genes in Castration-Resistant Prostate CancerLaura Cato, Jonas de Tribolet-Hardy, Irene Lee, et al.
Molecular Cancer Therapeutics|February 27, 2024
Thio-2 Inhibits Key Signaling Pathways Required for the Development and Progression of Castration-resistant Prostate CancerAntje Neeb, Ines Figueiredo, Denisa Bogdan, et al.
Nature Genetics|June 2, 2025
KDM4C inhibition blocks tumor growth in basal breast cancer by promoting cathepsin L-mediated histone H3 cleavageZheqi Li, Guillermo Peluffo, Laura E Stevens, et al.
Nature Communications|March 31, 2021
Reprogramming of the FOXA1 cistrome in treatment-emergent neuroendocrine prostate cancerSylvan C Baca, David Y Takeda, Ji-Heui Seo, et al.
Nature Cancer|April 26, 2021
EZH2 inhibition activates a dsRNA-STING-interferon stress axis that potentiates response to PD-1 checkpoint blockade in prostate cancerKatherine L Morel, Anjali V Sheahan, Deborah L Burkhart, et al.
Cancer Cell|January 15, 2020
Treatment-Induced Tumor Dormancy through YAP-Mediated Transcriptional Reprogramming of the Apoptotic PathwayKari J Kurppa, Yao Liu, Ciric To, et al.
Nature Genetics|July 22, 2020
Prostate cancer reactivates developmental epigenomic programs during metastatic progressionMark M Pomerantz, Xintao Qiu, Yanyun Zhu, et al.
Nature Communications|September 15, 2019
Perturbed myoepithelial cell differentiation in BRCA mutation carriers and in ductal carcinoma in situLina Ding, Ying Su, Anne Fassl, et al.
The Journal of Clinical Investigation|June 10, 2025
Patterns of intra- and inter-tumor phenotypic heterogeneity in lethal prostate cancerMartine P Roudier, Roman Gulati, Erolcan Sayar, et al.
Cell|March 1, 2025
HIF regulates multiple translated endogenous retroviruses: Implications for cancer immunotherapyQinqin Jiang, David A Braun, Karl R Clauser, et al.
Pageof 10